The 6‐year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes
Tiziana Magnani(Prostate Cancer UK), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), N. Bedini(Radiation Oncology Associates), S. Villà, T. Rancati(Fondazione IRCCS Istituto Nazionale dei Tumori), S. Donegani(Prostate Cancer UK), Giuseppe Procopio(Fondazione IRCCS Istituto Nazionale dei Tumori), Nicola Nicolai(Fondazione IRCCS Istituto Nazionale dei Tumori), R. Valdagni, Roberto Salvioni(Neurology, Inc), Lara Bellardita
Cited by 55
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
|Cellular and Molecular Life Sciences|2002|274